Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIMIG System for Peripheral Lung Cancer Diagnosis
NCT02111824Phase 1Terminated
- Sponsor
- Houston Methodist Research Institute
- Start
- Jan 2014
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
Phase 1, open-label trial (3 arms), sponsored by Houston Methodist Research Institute. Primary endpoint: Technical Success Rate of Biopsy Using the MIMIG system With + Without Fiber-Optical Imaging at 3 months. Started Jan 2014; status: terminated.
Beyond the preview
Go deeper on NCT02111824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02111824.